Frank Larsen

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Bipolar Disorder

Placebo Controlled

Top Venues

Clinical drug investigation

Neuropsychiatric disease and treatment

Current medical research and opinion

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew Harlin, Craig Chepke, Frank Larsen, Karimah S Bell Lynum, Sanjeda R Chumki, Heather M Fitzgerald, Pedro Such, Jessica-McDonough Madera, Murat Yildirim, Moeen Panni, Stephen R Saklad
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison. Neuropsychiatric disease and treatment 19 (2023)
Xue-Ning Li, Hong-Rong Xu, Ellen Cui, Kamilla Buchberg Petersen, Janka Ryding, Anders Ettrup, Jette Buch Østergaard, Frank Larsen
Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial. Clinical drug investigation (2023)
Matthew Harlin, Murat Yildirim, Pedro Such, Jessica-McDonough Madera, Michael Jan, Na Jin, Suzanne Watkin, Frank Larsen
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder. CNS drugs (2023)
Roger S McIntyre, Pedro Such, Murat Yildirim, Jessica-McDonough Madera, Zhen Zhang, Frank Larsen, Matthew Harlin
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study. Current medical research and opinion (2023)